Is a two-hour monitoring period sufficient and safe for patients undergoing ultrasound-guided percutaneous liver mass biopsy?: A prospective and multicenter experience

Basit Öğe Kaydı
dc.authoridKorkmaz, Mehmet/0000-0001-6234-9484
dc.authoridOZDEMIR, MUSTAFA/0000-0002-1934-5346
dc.authoridDENIZ, Muhammed Akif/0000-0002-9586-2425
dc.authoridArslan, Muhammet/0000-0001-5565-0770
dc.authoridTekinhatun, Muhammed/0000-0002-3240-6991
dc.authoridAlver, Kadir Han/0000-0002-4692-2401
dc.authoridKISBET, TANJU/0000-0002-9485-0959
dc.contributor.authorAslan, Halil Serdar
dc.contributor.authorArslan, Muhammet
dc.contributor.authorAlver, Kadir Han
dc.contributor.authorDemirci, Mahmut
dc.contributor.authorKorkmaz, Mehmet
dc.contributor.authorEsen, Kaan
dc.contributor.authorTurmak, Mehmet
dc.date.accessioned2025-02-22T14:09:10Z
dc.date.available2025-02-22T14:09:10Z
dc.date.issued2024
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurposeTo investigate whether patients undergoing percutaneous liver mass biopsy (PLMB) can be safely discharged following a two-hour monitoring period.MethodsA multi-center prospective analysis was conducted for 375 patients (196 males and 179 females), mean age 63 +/- 12.45 years (range 37-89) who underwent PLMB between August 2023 and March 2024. Patients were monitored for 24 h, and complications were classified as minor or major. The timing of complications was categorized into three groups: within the first two hours, between the 2nd and 24th hours, and within 1 week after 24 hours.ResultsMinor complications occurred in 18.93% (71/375) and major complications in 2.13% (8/375). Most minor complications (80.2%, 57/71) appeared within the first two hours, 12.7% (9/71) between 2 and 24 h, and 7.1% (5/71) after 24 h. All major complications (62.5%, 5/8) except late-onset cases, occurred within the first two hours. No major complications occurred between 2 and 24 h. Late-onset major complications occurred in 37.5% (3/8) after 24 h.ConclusionThe two-hour monitoring period did not adversely impact patient management regarding minor complications and is safe for identifying all major complications except for late-onset ones. Extending the post-biopsy recovery period does not significantly improve patient care. A two-hour observation period after PLMB, including hemogram monitoring and ultrasound, does not adversely affect patient management regarding minor complications and is safe and efficient for detecting significant complications except delayed ones. Extending recovery time does not significantly improve patient care, as delayed complications appear later. imageen_US
dc.identifier.doi10.1002/jcu.23795
dc.identifier.endpage1369en_US
dc.identifier.issn0091-2751
dc.identifier.issn1097-0096
dc.identifier.issue9en_US
dc.identifier.pmid39225264en_US
dc.identifier.scopus2-s2.0-85202918561en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1360en_US
dc.identifier.urihttps://doi.org/10.1002/jcu.23795
dc.identifier.urihttps://hdl.handle.net/11468/29817
dc.identifier.volume52en_US
dc.identifier.wosWOS:001303363900001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of Clinical Ultrasounden_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKA_WOS_20250222
dc.subjectliver mass biopsy complicationsen_US
dc.subjectmonitorization timeen_US
dc.titleIs a two-hour monitoring period sufficient and safe for patients undergoing ultrasound-guided percutaneous liver mass biopsy?: A prospective and multicenter experienceen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu